Furthermore, changes in the promoter region of MYH7 could be linked to the risk of developing HCM, and the patients harboring likely pathogenic or pathogenic variations in the MYH7 gene exhibited a higher incidence of developing new‐onset atrial fibrillation.115, 116, 117. Here, MYH7 is linked to atrial fibrillation.